Mueller Lukas L

Show results for

Unknown (3)
Transcriptomics (2)
Metabolomics (1)
Proteomics (1)

Organisms

Coffea arabica (1)
Homo sapiens (1)
Aerococcus urinae NBRC 15544 = CCUG 36881 (1)
Alteromonadales (1)
Apostichopus japonicus (1)
Canis lupus familiaris (1)
Carya cathayensis (1)
Clostridioides difficile 630 (1)
Cyanophora paradoxa (1)
Ensifer adhaerens (1)
Enterococcus faecalis (1)
Globicatella sanguinis (1)
Histomonas meleagridis (1)
Human immunodeficiency virus 1 (1)
Listeria monocytogenes (1)
Listeria monocytogenes EGD-e (1)
Methylohalobius crimeensis 10Ki (1)
Mus musculus (1)
Mycobacterium tuberculosis (1)
Ophrys garganica (1)
Ophrys sphegodes (1)
Pseudomonas aeruginosa SJTD-1 (1)
Pseudomonas putida KT2440 (1)
Rattus norvegicus (1)
Rhizobium sp. Leaf68 (1)
Schizosaccharomyces pombe 927 (1)
Schizosaccharomyces pombe 972h- (1)
Shigella (1)
Sphingomonas sp. Leaf257 (1)
Staphylococcus aureus (1)

Repository

biostudies-arrayexpress (2)
MetaboLights (1)
pride (1)

Tissue

Blood (1)
T cell (1)

Technology Type

Mass spectrometry (1)
Mass Spectrometry (1)
SWATH MS (1)

Instrument Platform

Exactive (Thermo Scientific) (1)

Publication Date

2013 (1)
2011 (1)
2016 (1)
2024 (1)

Metabolite Name

3-[(4-hydroxyphenyl)methyl]-octahydropyrrolo[1,2-a]pyrazine-1,4-dione (1)
(4aS,5R,6S,8aS)-5-[(3E)-5-methoxy-3-methyl-5-oxopent-3-en-1-yl]-5,6,8a-trimethyl-3,4,4a,5,6,7,8,8a-octahydronaphthalene-1-carboxylic acid (1)
5-(tert-butyl)-2-methyl-N-(5-methyl-3-isoxazolyl)-3-furamide (1)
2-{1-[2-({6-[4-(tert-butyl)phenoxy]-3-pyridinyl}amino)-2-oxoethyl]cyclopentyl}acetic acid (1)
Dodecyl sulfate (1)
2-[(3S)-1-(Cyclohexylmethyl)-3-pyrrolidinyl]-5-fluoro-1H-benzimidazole (1)
Enalaprilat (1)
ADB-FUBICA (1)
DL-2-(acetylamino)-3-phenylpropanoic acid (1)
5-{5-[(2S)-1-(2,2-Dimethylpropyl)-2-pyrrolidinyl]-1,2,4-oxadiazol-3-yl}-2-(2-methoxyethoxy)pyridine (1)
1-[1-({(3R,4S)-3-[(5-Butyl-1,2-oxazol-3-yl)methyl]-4-piperidinyl}acetyl)-4-piperidinyl]-1,3-dihydro-2H-benzimidazol-2-one (1)
Lignoceric acid (1)
2-Oxindole (1)
2,5-di-tert-Butylhydroquinone (1)
4-Hydroxy-2-methylbenzoic acid (1)
15(R)-Prostaglandin D2 (1)
4a,7b-Dihydroxy-3-(hydroxymethyl)-9a-(isobutyryloxy)-1,1,6,8-tetramethyl-5-oxo-1a,1b,4,4a,5,7a,7b,8,9,9a-decahydro-1H-cyclopropa[3,4]benzo[1,2-E]azulen-9-yl (2E)-2-methyl-2-butenoate (1)
(3beta,5xi,6alpha,9xi,12beta)-20-(beta-D-Glucopyranosyloxy)-3,12-dihydroxydammar-24-en-6-yl beta-D-glucopyranoside (1)
4-methyl-N-{[4-(5-propylpyrimidin-2-yl)-1,4-diazepan-1-yl]carbonyl}benzenesulfonamide (1)
10-HDA (1)
13Z,16Z-Docosadienoic Acid (1)
(3R,5S)-1-Isopropyl-5-[3-(3-pyridinyl)-1,2,4-oxadiazol-5-yl]-3-pyrrolidinol (1)
Furazolidone (1)
(1S,6R,11aR,13R,14aS)-1,13-dihydroxy-6-methyl-1H,4H,6H,7H,8H,9H,11aH,12H,13H,14H,14aH-cyclopenta[f]oxacyclotridecan-4-one (1)
2-(8-Hydroxy-4a,8-dimethyldecahydro-2-naphthalenyl)acrylic acid (1)
4-(3-ethyl-5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-2-(3-pyridyl)-1,3-thiazole hydrobromide (1)
NP-002477 (1)
(+/-)18-HEPE (1)
Vermixocin B (1)
2,6-di-tert-Butylphenol (1)

Study type

Transcription profiling by array (2)

Release Date

2013 (1)
2011 (1)
2024 (1)
2016 (1)
2012 (1)

Lab affiliation

Department of Dermatology and Venereology, University of Cologne, Faculty of Medicine, and University Hospital of Cologne, Cologne, Germany (1)

Previous page
1 / 1
You're on page 1
Next page

Sort by:

Relevance

Page size

Improving global feature detectabilities through scan range splitting for untargeted metabolomics by high-performance liquid chromatography-Orbitrap mass spectrometry

Untargeted metabolomics aims at obtaining quantitative information on the highest possible number of low-molecular biomolecules present in a biological sample. Rather small changes in mass spectrometric spectrum acquisition parameters may have a significant influence on the detectabilities of metabo...

2016-06-09 | MTBLS233 | MetaboLights

PHH Chlorpromazine

Drug induced liver injury (DILI) is still a major reason for drug attrition during clinical trials and market-withdrawal of already approved drugs. DILI is difficult to predict in animal models, hence more suitable screening methods are needed to predict adverse effects in human. Here, transcriptom...

ORGANISM(S): Homo sapiens

2013-08-05 | E-MTAB-1747 | biostudies-arrayexpress

Imiquimod in human CD8+ T cells

Blood CD8 T cells from six healthy blood donors were treated with the TLR7 agonist imiquimod + IL-2 in T cell enriched medium overnight in vitro (the controls were incubated with T cell enriched medium + IL-2 only). After approx. 21 h the in solution digest protocol was started.

ORGANISM(S): Homo sapiens (Human)

2024-04-29 | PXD038621 | Pride

Imiquimod Cd8 t cells

Glutamine promotes human CD8⁺ T cells and counteracts imiquimod-induced T cell hyporesponsiveness.

Not available

S-EPMC11088342 | biostudies-literature

The 'PUCE CAFÉ' project: A genome-wide 15K coffee microarray, a new tool to discover candidate genes correlated to quality traits

Background: Understanding the genetic elements that contribute to key aspects of coffee biology will impact future agronomical improvements for this economically important tree. The past years, EST collections were generated in Coffee, opening the possibility to create new tools for functional genom...

ORGANISM(S): Coffea arabica

2011-11-01 | E-GEOD-24754 | biostudies-arrayexpress

Low-dose budesonide for maintenance of clinical remission in collagenous colitis: a randomised, placebo-controlled, 12-month trial.

Not available

S-EPMC4717436 | biostudies-literature

Using CSF biomarkers to replicate genetic associations in Alzheimer's disease.

Not available

S-EPMC3150628 | biostudies-literature

Previous page
1 / 1
You're on page 1
Next page

Sort by:

Relevance

Page size

7 Results

Show results for

Organisms

Repository

Tissue

Technology Type

Instrument Platform

Publication Date

Metabolite Name

Study type

Release Date

Lab affiliation

OmicsDI is part of the ELIXIR infrastructure

Tweets